Clinical Trial Update: Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial in Chinese adults with obesity is evaluating the efficacy and safety of Semaglutide Injection compared with Wegovy (semaglutide). The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Semaglutide injection (semaglutide)
• WEGOVY (Semaglutide)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Obesity Control | Phase 3 | Status: RECRUITING